GYROSCOPE CAPITAL MANAGEMENT GROUP, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 140 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
GYROSCOPE CAPITAL MANAGEMENT GROUP, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2018$30,000
-36.2%
16,0000.0%0.01%
-42.1%
Q3 2018$47,000
-2.1%
16,0000.0%0.02%
-9.5%
Q2 2018$48,00016,0000.02%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$51,946,0002.80%
MILLER VALUE PARTNERS, LLC 4,900,721$26,219,0001.15%
MSD Partners, L.P. 3,410,500$18,246,0000.92%
Michael & Susan Dell Foundation 66,749$357,0000.26%
Glacier Peak Capital LLC 68,043$364,0000.21%
Vident Investment Advisory, LLC 114,980$615,0000.08%
SFMG, LLC 62,433$334,0000.07%
Virtus ETF Advisers LLC 40,359$216,0000.06%
Steward Partners Investment Advisory, LLC 23,187$124,0000.06%
O'Dell Group, LLC 10,142$54,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders